Updated:
GMO
GMO is a Boston-based asset manager co-founded by Jeremy Grantham in 1977, running ~$65B in systematic value strategies across global markets.
GMO
GMO was founded in 1977 by Jeremy Grantham, Richard Mayo, and Eyk van Otterloo as a Boston-based asset manager rooted in systematic value investing. The firm's wealth-origin is not a family fortune but the success of its founding partners, with Grantham's investment reputation and environmental philanthropy defining its public profile. GMO's strategy is built on a quantitative, long-term value discipline, analyzing global markets through proprietary models that assess valuation, economic cycles, and sentiment. The firm covers asset classes including global equities, fixed income, and multi-asset portfolios, with a focus on deep value and quality factors. Known positions have included holdings in emerging markets and U.S. value stocks, with a history of contrarian bets such as the 1999 tech bubble warning. Geographic footprint spans North America, Europe, and Asia, with offices in Boston, Mountain View, and Dubai. The firm manages approximately $65 billion in client assets as of 2024, serving institutional investors globally through separate accounts and pooled vehicles. GMO employs over 400 professionals, with a significant team of quantitative researchers and portfolio managers. Adjacent entities include Grantham Foundation for the Protection of the Environment, a philanthropic arm focused on climate change and biodiversity. In 2024, the firm signaled a cautious stance on U.S. equities, citing elevated valuations (per Bloomberg, 2024). GMO's structural differentiator is its uncompromising value discipline and contrarian culture, amplified by Grantham's outspoken market commentary. Unlike many asset managers that modulate strategy, GMO holds conviction-heavy positions against consensus, a model that has produced both spectacular outperformance and extended drawdowns, creating a dedicated institutional following.
General information
Firm type
Asset Manager
Year founded
1977
AUM
$65B USD (per the firm, 2024)
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
Mountain View, CA, United States · Wilmington, DE, United States · Dubai, United Arab Emirates
Principals
Jeremy Grantham
Co-Founder and Long-Term Investment Strategist
Ben Inker
Co-Head of Asset Allocation
Tom Hancock
Co-Head of Asset Allocation
Ted Darling
Chief Executive Officer
Sector focus
Frequently asked questions
Who manages investment decisions at GMO?
GMO's investment decisions are led by a team of portfolio managers, with Ben Inker and Tom Hancock co-heading asset allocation. Jeremy Grantham serves as Long-Term Investment Strategist, providing macro commentary. The firm's quantitative models are designed by a large research team, with oversight from the investment committee.
How does GMO source investment ideas and generate returns?
GMO uses a proprietary quantitative framework that screens global markets for value, quality, and sentiment anomalies. Ideas emerge from systematic models rather than discretionary stock-picking, with the firm's edge in long-term horizon analysis and contrarian positioning. The approach has been publicly detailed in white papers and commentary (per the firm).
What investment stages and asset classes does GMO target?
GMO targets publicly traded securities across equities, fixed income, and multi-asset portfolios. It does not typically engage in private equity or venture stages. Strategies include U.S. value, international value, emerging markets, and target-date funds, all through liquid, systematic approaches.
Is GMO a family office or an asset manager?
GMO is an institutional asset manager, not a family office. It manages assets for pension funds, endowments, and other institutions, with founders' personal wealth also invested in its strategies. The firm's structure is that of a registered investment advisor, not a family office.
How is GMO related to Jeremy Grantham's environmental philanthropy?
Jeremy Grantham co-founded the Grantham Foundation for the Protection of the Environment, separate from GMO. The foundation supports climate and biodiversity initiatives, with Grantham's philanthropic identity distinct from his role at GMO. The two entities operate independently.
What is GMO's known posture on co-investments with other managers?
GMO does not typically engage in co-investments alongside external GPs. Its business model is direct management of client assets through its own funds and separate accounts, focused on public markets via systematic strategies.
Does GMO explicitly avoid certain sectors or strategies?
GMO avoids high-growth, low-quality, and heavily speculative sectors, particularly those trading at extreme valuations. It has historically steered away from technology stocks during bubble periods, and generally does not invest in private markets, commodities, or currencies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: